|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows used in operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Share-based compensation expense | |
| Related Party | |
| Nonrelated Party | |
| Share-based charitable contribution expense | |
| Change in fair value as a result of fair value remeasurements | |
| Series A and Series B Convertible Notes inducement expense | |
| Foreign exchange (gain) loss, net | |
| Other non-cash activities | |
| Changes in operating assets and liabilities: | |
| Accounts payable and accrued liabilities | |
| Prepaid expenses and other assets | |
| Net cash used in operating activities | |
| Cash flows used in investing activities: | |
| Investments in property, plant, and equipment | |
| Other investing activities | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from issuance of Series A Convertible Notes | |
| Proceeds from issuance of Seed Convertible Notes | |
| Proceeds from issuance of Preferred Units | |
| Proceeds from issuance of Macquarie Term Loan | |
| Payment of Promissory Note | |
| Payment of debt issuance costs | |
| Payment of offering costs | |
| Proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions | |
| Other financing activities | |
| Net cash provided by financing activities | |
| Change in cash and cash equivalents | |
| Cash and cash equivalents, at beginning of period | |
| Cash, cash equivalents and restricted cash, at end of period |
Loading...
